Conantokin G
This compound is a selective and competitive GluN2B (NR2B) subunit-containing NMDA receptor antagonist, with an IC50 of approximately 300-480 nM. It demonstrates neuroprotective effects in both cellular and animal models, making it a valuable research tool for studying excitotoxicity, stroke, and neurological disorders.
Product Specifications
Field of Research
Neuroscience, Pharmacology & Drug Discovery
Molecular Weight
2264.21
Storage Conditions
-20°C
Notes
For research use only.
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15351618 1 Vial
Lentiviral human RSPO4 shRNA (UAS) - Lentiviral human RSPO4 shRNA (UAS, iRFP) (100)
Sign In for Pricing
View Details